More on crsp

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.6 Score)
- Holders

Upcoming Events

- Earnings (11/4/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CRISPR Therapeutics (NQ:CRSP)
Delayed: 53.39 +2.95 (5.85%)
Prev. Close $50.44  
Open$50.82 
52 Wk High$18.88 
52 Wk Low$13.75 
Day High$54.07 
Day Low$50.52 
P/E N/A  
EPS$0.00 
Volume1,472,143 

Friends, Peers and Foes (?): NTLA, DNTH, ARWR, AGMB, BEAM (more...)

Oct 9, 2026 06:51 AM H.C. Wainwright Reiterates Buy Rating on CRISPR Therapeutics (CRSP)
Oct 8, 2026 05:35 PM Form 4 CRISPR Therapeutics AG For: Oct 06 Filed by: KASINGER JAMES R.
Oct 8, 2026 08:30 AM CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026
Oct 6, 2026 04:47 PM Form 144 CRISPR Therapeutics AG Filed by: KASINGER JAMES R.
Oct 2, 2026 10:15 AM CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026
Sep 28, 2026 11:50 AM Form 4 CRISPR Therapeutics AG For: Sep 22 Filed by: KASINGER JAMES R.
Sep 28, 2026 04:30 AM CRISPR Therapeutics (CRSP) Reiterated at Market Outperform by Citizens on Pipeline Opportunity
Sep 24, 2026 05:35 PM Form 4 CRISPR Therapeutics AG For: Sep 22 Filed by: KASINGER JAMES R.
Sep 23, 2026 02:07 PM Anthropic's Claude AI identifies novel enzyme system in DNA search
Sep 22, 2026 04:43 PM Form 144 CRISPR Therapeutics AG Filed by: KASINGER JAMES R.
View All Articles

Entities mentioned with crsp

View All Entities